Mellon Medical B.V.

Mellon Medical B. V. , based in the Netherlands, specializes in the development of innovative medical devices and technologies aimed at enhancing patient care across diverse healthcare environments. Founded in 2013 and headquartered in Delft, Netherlands, Mellon Medical B.

V. focuses on developing advanced medical devices. The company has completed four funding deals, with the latest being a Series B round that raised EUR 4. 00 mn from investors including BOM Brabant Ventures, BioGeneration Ventures, DEMCON, Oost NL, and Thuja Capital.

The CEO of the company is Jan Benschop. Mellon Medical specializes in innovative healthcare solutions, focusing primarily on developing advanced medical devices and technologies aimed at improving patient care. The company’s core product offerings include state-of-the-art diagnostic tools and therapeutic devices designed to enhance clinical outcomes in various healthcare settings. These products serve a diverse client base comprising hospitals, outpatient clinics, and healthcare professionals, who rely on them to address critical health issues such as chronic disease management and diagnostic accuracy.

Released over the past few years, these offerings highlight Mellon Medical's commitment to integrating technology into everyday medical practice. The company’s products are marketed primarily in North America and select European countries, aiming to meet the demands of healthcare providers operating in these regions. Mellon Medical generates revenue through a structured business model that includes direct sales to healthcare institutions and partnerships with medical distributors. The company engages in B2B transactions, where hospitals and clinics procure its flagship diagnostic and therapeutic devices directly.

These transactions often involve contractual arrangements that may include volume-based pricing agreements, ensuring that clients benefit from competitive rates based on their purchasing needs. Additionally, the company offers subscription-based services for ongoing support and software updates related to their devices, thereby creating a recurring revenue stream. The transactions are designed to facilitate seamless integration of Mellon Medical's products into healthcare workflows, ensuring that end-users can deliver improved patient outcomes effectively. Mellon Medical B.

V. is set to utilize its recent funding for the development of new products aimed at enhancing patient care, though specific product launch timelines have not been disclosed. The company is also exploring expansion into new markets, specifically targeting additional locations in North America and Europe over the next few years. The recent venture funding from MaasInvest will support these initiatives.